Evidence map›Paper›PMID 35788551›Full record

ReviewOphthalmology and therapy2022

Pythium insidiosum Keratitis: Past, Present, and Future.

Bharat Gurnani, Kirandeep Kaur, Shweta Agarwal, Vaitheeswaran G Lalgudi, Nakul S Shekhawat, Anitha Venugopal, Koushik Tripathy, Bhaskar Srinivasan, Geetha Iyer, Joseph Gubert

Open access · goldAbstract readReview
In one paragraph

Review in Ophthalmology and therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Molecular Detection ofAnimals : an open access journal from MDPI · 2025
    Article
  4. Renaissance of an Emerging Pathogen-Clinical ophthalmology (Auckland, N.Z.) · 2025
    Article
  5. Immune Camouflage inClinical ophthalmology (Auckland, N.Z.) · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Pythium insidiosum: insights into biofilm formation and antibiofilm activity of antifungal drugs.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Bharat GurnaniAravind Eye Hospital and Post Graduate Institute of Ophthalmology, Pondicherry, 605007, India. drgurnanibharat25@gmail.com.ORCID http://orcid.org/0000-0003-0848-5172
Kirandeep KaurAravind Eye Hospital and Post Graduate Institute of Ophthalmology, Pondicherry, 605007, India.ORCID http://orcid.org/0000-0002-0951-7415
Shweta AgarwalDr G Sitalakshmi Memorial Clinic for Ocular Surface Disorders, CJ Shah Cornea Services, Medical Research Foundation, Sankara Nethralaya, 18 College Road, Chennai, Tamil Nadu, 600006, India.ORCID http://orcid.org/0000-0003-4515-1374
Vaitheeswaran G LalgudiThe Ottawa Hospital, University of Ottawa Eye Institute, Ottawa, ON, Canada.ORCID http://orcid.org/0000-0003-1677-1320
Nakul S ShekhawatWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, USA.ORCID http://orcid.org/0000-0003-4472-3852
Anitha VenugopalAravind Eye Hospital and Postgraduate Institute of Ophthalmology, Tirunelveli, Tamil Nadu, India.ORCID http://orcid.org/0000-0002-7412-380X
Koushik TripathyASG Eye Hospital, BT Road, Kolkata, 70058, India.ORCID http://orcid.org/0000-0002-9756-128X
Bhaskar SrinivasanDr G Sitalakshmi Memorial Clinic for Ocular Surface Disorders, CJ Shah Cornea Services, Medical Research Foundation, Sankara Nethralaya, 18 College Road, Chennai, Tamil Nadu, 600006, India.
Geetha IyerDr G Sitalakshmi Memorial Clinic for Ocular Surface Disorders, CJ Shah Cornea Services, Medical Research Foundation, Sankara Nethralaya, 18 College Road, Chennai, Tamil Nadu, 600006, India.ORCID http://orcid.org/0000-0002-7903-9500
Joseph GubertDepartment of Microbiology, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Pondicherry, 605007, India.ORCID http://orcid.org/0000-0002-6053-7120
Aravind Eye Hospital · INSankara Nethralaya · INJohns Hopkins University · USUniversity of Ottawa · CA

Funding

Improving Outcomes Assessment for Microbial KeratitisK23EY032988 · NEI · JOHNS HOPKINS UNIVERSITY · PI Nakul Shekhawat · 2022 to 2026
$1.1M
NEI NIH HHS K23 EY032988
6 · The paper itself

Abstract

Pythium insidiosum (PI) is an oomycete, a protist belonging to the clade Stramenopila. PI causes vision-threatening keratitis closely mimicking fungal keratitis (FK), hence it is also labeled as "parafungus". PI keratitis was initially confined to Thailand, USA, China, and Australia, but with growing clinical awareness and improvement in diagnostic modalities, the last decade saw a massive upsurge in numbers with the majority of reports coming from India. In the early 1990s, pythiosis was classified as vascular, cutaneous, gastrointestinal, systemic, and ocular. Clinically, morphologically, and microbiologically, PI keratitis closely resembles severe FK and requires a high index of clinical suspicion for diagnosis. The clinical features such as reticular dot infiltrate, tentacular projections, peripheral thinning with guttering, and rapid limbal spread distinguish it from other microorganisms. Routine smearing with Gram and KOH stain reveals perpendicular septate/aseptate hyphae, which closely mimic fungi and make the diagnosis cumbersome. The definitive diagnosis is the presence of dull grey/brown refractile colonies along with zoospore formation upon culture by leaf induction method. However, culture is time-consuming, and currently polymerase chain reaction (PCR) method is the gold standard. The value of other diagnostic modalities such as confocal microscopy and immunohistopathological assays is limited due to cost, non-availability, and limited diagnostic accuracy. PI keratitis is a relatively rare disease without established treatment protocols. Because of its resemblance to fungus, it was earlier treated with antifungals but with an improved understanding of its cell wall structure and absence of ergosterol, this is no longer recommended. Currently, antibacterials have shown promising results. Therapeutic keratoplasty with good margin (1 mm) is mandated for non-resolving cases and corneal perforation. In this review, we have deliberated on the evolution of PI keratitis, covered all the recently available literature, described our current understanding of the diagnosis and treatment, and the potential future diagnostic and management options for PI keratitis.

Indexed as

AzithromycinKeratitisLeaf incarnation methodLinezolidParafungusPythium insidiosumTherapeutic keratoplastyZoospore

Identifiers

PMID35788551
PMCPMC9255487
OpenAlexW4283806824

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.